Savitz Adam 4
4 · Alto Neuroscience, Inc. · Filed Feb 7, 2024
Insider Transaction Report
Form 4
Savitz Adam
CHIEF MEDICAL OFFICER
Transactions
- Conversion
Common Stock
2024-02-06+7,851→ 7,851 total(indirect: By Trust) - Conversion
Series B Preferred Stock
2024-02-06−16,666→ 0 total(indirect: By Trust)→ Common Stock (7,851 underlying) - Purchase
Common Stock
2024-02-06$16.00/sh+17,000$272,000→ 24,851 total(indirect: By Trust)
Footnotes (2)
- [F1]Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date.
- [F2]The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust.